IndiQube's 34% revenue surge to ₹400 crore in Q4 FY26 is impressive, but the ₹22.7 crore loss suggests operational inefficiencies. As incumbents like Indoco Remedies and Indiamart Intermesh also report profit declines despite revenue growth, it's clear that scaling doesn't guarantee profitability. How are these companies addressing the tension between growth and sustainable margins?